Enhanced surveillance for new vaccine‑preventable diseases
Official title: IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
Funded at Vanderbilt University Medical Center · NIH-11624131 · Data updated 2026-11-12
A Vanderbilt team is tracking how well vaccines work and how diseases like flu, RSV, norovirus, and SARS‑CoV‑2 affect young children over time.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | September 1, 2021 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $150,000 |
| NIH project number | 6U01IP001156-05M003 |
| Project ID | NIH-11624131 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children under the age of six months and older who experience acute respiratory illness or acute gastroenteritis and participate in ongoing surveillance.
✕Less likely to help
Some participants may not experience direct personal benefit beyond contributing to population‑level knowledge.
What this research studies
This project follows children with acute respiratory illnesses and gastroenteritis to identify which pathogens are causing illness, how severe outcomes are, and how vaccines influence these patterns. Researchers will collect data and samples over several years to monitor for changes in viruses and the effectiveness of vaccines against them. The work will help families understand which vaccines are most impactful and how future vaccination strategies could protect kids better. It is designed to inform public health decisions and improve prevention of common childhood infections.
Why it matters
Potential benefit: If successful, the project could improve vaccine strategies and reduce severe outcomes from common childhood infections.
How similar studies have gone: Previous surveillance efforts have helped refine vaccine policies and track circulating pathogens, with ongoing improvements in understanding VE over time.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Halasa, Natasha Bassam — Vanderbilt University Medical Center
- Study coordinator: Halasa, Natasha Bassam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.